News Archive Navigation
icon
Showing 125 results
February 2023
-
Media ReleaseNovartis broadens access to innovative medicines, leverages data & digital for enhanced cancer care in PHNovartis continuously finds ways to help improve the quality of care for Filipino patients living with cancer, which is one of the leading causes of illness and death in the Philippines. In…
-
Media ReleaseNovartis associates take on challenge to unblock barriers to better cardiovascular healthTo help reduce the heavy burden of cardiovascular diseases (CVDs), Novartis launched the Unblocked movement for heart health – an initiative co-created with external stakeholders in the healthcare…
-
Media ReleaseNovartis: Working with DOH and other partners to end leprosyNovartis and the Novartis Foundation have been working with the Department of Health and other partners to eliminate leprosy for over 30 years. The Novartis Foundation focuses on influencing…
January 2023
-
Media Release Achievements and AnnouncementsCareersNovartis Healthcare Philippines recognized as a Top Employer for third consecutive yearNovartis Healthcare Philippines has been officially recognized by the Top Employers Institute as a Top Employer 2023 in the Philippines. To become recognized as a Top Employer, an organization…
-
Media Release Partnerships and CommitmentsBreast CancerICanServe, Taguig City, Dashlabs, Novartis launch data-digital project to support breast cancer control programThe ICanServe Foundation, City of Taguig, local healthcare software startup Dashlabs, and Novartis have launched the Circle of Life Data and Digital Infrastructure project to support the Ating…
November 2022
-
Media ReleaseNovartis partners with DOH, medical societies, hospitals to strengthen healthcare system and improve heart failure management in PHIn a developing country like the Philippines, where healthcare delivery is mostly paid through patients' out-of-pocket expenses, the economic burden of heart failure (HF), especially…
-
Media ReleaseNovartis recognized for supporting eye health services amid pandemicNovartis Healthcare Philippines was recognized by the National Committee for Sight Preservation (NCSP) for the company’s support to the NCSCP “Maging MATAlino”…
September 2022
-
Media ReleasePhilippine FDA approves Novartis drug, ribociclib, for advanced breast cancer in malesThe Philippine Food and Drug Administration (FDA) has approved ribociclib for the treatment of metastatic breast cancer. Ribociclib in combination with an aromatase inhibitor or fulvestrant…
-
Novartis supports the Southeast Asian Breast Cancer Symposium
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 11
- › Next page